• Molecular NameSodium stibogluconate
  • SynonymNA
  • Weight907.876
  • Drugbank_IDDB05630
  • ACS_NO16037-91-5
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-5.91
  • pkaN/A
  • LogD (pH=7, predicted)-10.9
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)N/A
  • LogSw (predicted, AB/LogsW2.0)40423.0
  • Sw (mg/ml) (predicted, ACD/Labs)N/A
  • No.of HBond Donors8
  • No.of HBond Acceptors17
  • No.of Rotatable Bonds8
  • TPSA260.59
  • StatusFDA approved
  • AdministrationIV only
  • PharmacologyA medicine used to treat leishmaniasis and is only available for administration by injection.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityThe main symptoms of antimony overdosage are gastro-intestinal disturbances (nausea, vomiting and severe diarrhoea). Haemorrhagic nephritis and hepatitis may also occur.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A